1156 related articles for article (PubMed ID: 12414634)
41. Lentiviral vector gene transfer into fetal rhesus monkeys (Macaca mulatta): lung-targeting approaches.
Tarantal AF; Lee CI; Ekert JE; McDonald R; Kohn DB; Plopper CG; Case SS; Bunnell BA
Mol Ther; 2001 Dec; 4(6):614-21. PubMed ID: 11735346
[TBL] [Abstract][Full Text] [Related]
42. [Expression of enhanced green fluorescent protein in transduced variant HT-29c cells in vitro and in vivo].
Wang M; Lars B; Bradley HD; Ilka V; Holger K
Zhonghua Wai Ke Za Zhi; 2002 May; 40(5):372-4. PubMed ID: 12133346
[TBL] [Abstract][Full Text] [Related]
43. Efficient gene transfer of CD40 ligand into ovarian carcinoma cells with a recombinant adeno-associated virus vector.
Koppold B; Sauer G; Büning H; Hallek M; Kreienberg R; Deissler H; Kurzeder C
Int J Oncol; 2005 Jan; 26(1):95-101. PubMed ID: 15586229
[TBL] [Abstract][Full Text] [Related]
44. Anticancer effect of a lentiviral vector capable of expressing HIV-1 Vpr.
Pang S; Kang MK; Kung S; Yu D; Lee A; Poon B; Chen IS; Lindemann B; Park NH
Clin Cancer Res; 2001 Nov; 7(11):3567-73. PubMed ID: 11705878
[TBL] [Abstract][Full Text] [Related]
45. Ex vivo and in vitro studies of transgene expression in rat astrocytes transduced with lentiviral vectors.
Ericson C; Wictorin K; Lundberg C
Exp Neurol; 2002 Jan; 173(1):22-30. PubMed ID: 11771936
[TBL] [Abstract][Full Text] [Related]
46. The use of the L-plastin promoter for adenoviral-mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines.
Peng XY; Won JH; Rutherford T; Fujii T; Zelterman D; Pizzorno G; Sapi E; Leavitt J; Kacinski B; Crystal R; Schwartz P; Deisseroth A
Cancer Res; 2001 Jun; 61(11):4405-13. PubMed ID: 11389068
[TBL] [Abstract][Full Text] [Related]
47. Improved lentiviral vectors for Wiskott-Aldrich syndrome gene therapy mimic endogenous expression profiles throughout haematopoiesis.
Frecha C; Toscano MG; Costa C; Saez-Lara MJ; Cosset FL; Verhoeyen E; Martin F
Gene Ther; 2008 Jun; 15(12):930-41. PubMed ID: 18323794
[TBL] [Abstract][Full Text] [Related]
48. Expression and recombination of the EGFP and EYFP genes in lentiviral vectors carrying two heterologous promoters.
Dijon M; Torne-Celer C; Moreau T; Tonnelle C; Chabannon C
Cytotherapy; 2005; 7(5):417-26. PubMed ID: 16236631
[TBL] [Abstract][Full Text] [Related]
49. HIV-1-derived lentiviral vectors and fetal route of administration on transgene biodistribution and expression in rhesus monkeys.
Jimenez DF; Lee CI; O'Shea CE; Kohn DB; Tarantal AF
Gene Ther; 2005 May; 12(10):821-30. PubMed ID: 15815706
[TBL] [Abstract][Full Text] [Related]
50. Molecular evidence of lentiviral vector-mediated gene transfer into human self-renewing, multi-potent, long-term NOD/SCID repopulating hematopoietic cells.
Ailles L; Schmidt M; Santoni de Sio FR; Glimm H; Cavalieri S; Bruno S; Piacibello W; Von Kalle C; Naldini L
Mol Ther; 2002 Nov; 6(5):615-26. PubMed ID: 12409260
[TBL] [Abstract][Full Text] [Related]
51. The secretory leukoprotease inhibitor (SLPI) promoter for ovarian cancer gene therapy.
Barker SD; Coolidge CJ; Kanerva A; Hakkarainen T; Yamamoto M; Liu B; Rivera AA; Bhoola SM; Barnes MN; Alvarez RD; Curiel DT; Hemminki A
J Gene Med; 2003 Apr; 5(4):300-10. PubMed ID: 12692864
[TBL] [Abstract][Full Text] [Related]
52. Transduction of ovarian cancer cells: a recombinant adeno-associated viral vector compared to an adenoviral vector.
Vermeij J; Zeinoun Z; Neyns B; Teugels E; Bourgain C; De Grève J
Br J Cancer; 2001 Nov; 85(10):1592-9. PubMed ID: 11720450
[TBL] [Abstract][Full Text] [Related]
53. [Construction of a lentiviral vector carrying human bcl-2 gene and its expression in human ovarian granulosa cells].
Wang XF; He YL
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1856-9. PubMed ID: 18971189
[TBL] [Abstract][Full Text] [Related]
54. Targeting of prostate cancer cells by a cytotoxic lentiviral vector containing a prostate stem cell antigen (PSCA) promoter.
Petrigliano FA; Virk MS; Liu N; Sugiyama O; Yu D; Lieberman JR
Prostate; 2009 Sep; 69(13):1422-34. PubMed ID: 19489029
[TBL] [Abstract][Full Text] [Related]
55. Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors.
Kikuchi E; Menendez S; Ozu C; Ohori M; Cordon-Cardo C; Logg CR; Kasahara N; Bochner BH
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4511-8. PubMed ID: 17671137
[TBL] [Abstract][Full Text] [Related]
56. Expression of human factor IX gene in murine plasma through lentiviral vector-infected haematopoietic stem cells.
Chen H; Yao H; Huang L; Shen Q; Jia W; Xue J
Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1196-201. PubMed ID: 17184501
[TBL] [Abstract][Full Text] [Related]
57. Gene transfer into stimulated and unstimulated T lymphocytes by HIV-1-derived lentiviral vectors.
Costello E; Munoz M; Buetti E; Meylan PR; Diggelmann H; Thali M
Gene Ther; 2000 Apr; 7(7):596-604. PubMed ID: 10819575
[TBL] [Abstract][Full Text] [Related]
58. Comparison of HIV- and EIAV-based vectors on their efficiency in transducing murine and human hematopoietic repopulating cells.
Siapati EK; Bigger BW; Miskin J; Chipchase D; Parsley KL; Mitrophanous K; Themis M; Thrasher AJ; Bonnet D
Mol Ther; 2005 Sep; 12(3):537-46. PubMed ID: 16099415
[TBL] [Abstract][Full Text] [Related]
59. Highly efficient lentiviral gene transfer in CD34+ and CD34+/38-/lin- cells from mobilized peripheral blood after cytokine prestimulation.
Géronimi F; Richard E; Redonnet-Vernhet I; Lamrissi-Garcia I; Lalanne M; Ged C; Moreau-Gaudry F; De Verneuil H
Stem Cells; 2003; 21(4):472-80. PubMed ID: 12832700
[TBL] [Abstract][Full Text] [Related]
60. [Transduction of recombinant marrow stem cells using lentiviral vector and adenoviral vector: a comparative study].
Ma XS; Jiang JY; Lü FZ; Ma X; Li XK; Huang HY
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(47):3340-4. PubMed ID: 17313830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]